We share the Government’s ambition of making the UK a leading global hub for life sciences and an internationally competitive trading partner with the EU and the world.
For us, securing our reputation as an attractive destination for global investment is key, but as an industry, our priority is a future trading relationship with the EU based on cooperation
We believe that the relationship between the UK and the EU should be based around three objectives:
- Ensuring UK and EU patients have uninterrupted supply of their current treatments and fast access to new medicines.
- Safeguarding the current high global regulatory standards and public health protections for medicines used to treat UK and EU patients.
- Retaining the UK’s position as a global leader in life sciences innovation and increasing its international influence in shaping life sciences policy.
To achieve this, there four key areas for negotiators on both sides to work within and reach a pragmatic and positive future relationship: